• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record

    6/25/25 8:55:00 AM ET
    $GKOS
    $ICE
    $JBS
    Medical/Dental Instruments
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $GKOS alert in real time by email

    NEW YORK, June 25, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Kristen Scholer delivers the pre-market update on June 25th

    • Equities are little changed Wednesday morning after jumping by more than 1% on Tuesday. The DOW gained over 500 points while the S&P 500 sits just shy of a record high.
    • Driving those gains were easing tensions in the Middle East, resulting in crude oil prices falling by approximately 5% during Tuesday's session. President Trump announced a ceasefire agreement on Monday night.
    • Fed Chair Powell reiterated the Central Bank's wait-and-see approach to cutting interest rates in a testimony before the House Financial Services Committee on Tuesday. The Fed last cut rates in December.

    Opening Bell

    JBS N.V. (NYSE:JBS) celebrates its recent listing

    Closing Bell

    Glaukos Corporation (NYSE:GKOS) celebrates the 10th anniversary of its IPO

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--sp-500-trades-within-1-of-record-302490894.html

    SOURCE New York Stock Exchange

    Get the next $GKOS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GKOS
    $ICE
    $JBS

    CompanyDatePrice TargetRatingAnalyst
    Glaukos Corporation
    $GKOS
    10/27/2025$120.00Equal Weight → Overweight
    Wells Fargo
    Intercontinental Exchange Inc.
    $ICE
    10/13/2025$210.00Outperform → Strong Buy
    Raymond James
    Glaukos Corporation
    $GKOS
    10/1/2025$103.00Buy
    Goldman
    JBS N.V.
    $JBS
    6/26/2025$20.00Outperform
    BMO Capital Markets
    JBS N.V.
    $JBS
    6/18/2025$21.00Buy
    BofA Securities
    Glaukos Corporation
    $GKOS
    5/1/2025$86.00Overweight → Equal Weight
    Wells Fargo
    Glaukos Corporation
    $GKOS
    2/19/2025$140.00 → $200.00Neutral → Outperform
    Mizuho
    Glaukos Corporation
    $GKOS
    12/11/2024$132.00 → $162.00Neutral → Buy
    Citigroup
    More analyst ratings

    $GKOS
    $ICE
    $JBS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. sold $33,075 worth of shares (315 units at $105.00), decreasing direct ownership by 0.62% to 50,488 units (SEC Form 4)

    4 - GLAUKOS Corp (0001192448) (Issuer)

    11/26/25 5:00:13 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Gardiner Warren sold $241,538 worth of shares (1,572 units at $153.65), decreasing direct ownership by 7% to 20,534 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    11/24/25 4:30:08 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    General Counsel Surdykowski Andrew J exercised 1,770 shares at a strike of $50.01 and sold $269,960 worth of shares (1,770 units at $152.52) (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    11/21/25 4:35:03 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    SEC Filings

    View All

    SEC Form 6-K filed by JBS N.V.

    6-K - JBS N.V. (0001791942) (Filer)

    11/25/25 5:25:45 PM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    SEC Form 6-K filed by JBS N.V.

    6-K - JBS N.V. (0001791942) (Filer)

    11/20/25 6:48:44 PM ET
    $JBS
    Meat/Poultry/Fish
    Consumer Staples

    SEC Form 144 filed by Intercontinental Exchange Inc.

    144 - Intercontinental Exchange, Inc. (0001571949) (Subject)

    11/20/25 4:23:24 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Glaukos upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Glaukos from Equal Weight to Overweight and set a new price target of $120.00

    10/27/25 8:30:13 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    Intercontinental Exchange upgraded by Raymond James with a new price target

    Raymond James upgraded Intercontinental Exchange from Outperform to Strong Buy and set a new price target of $210.00

    10/13/25 8:40:25 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Goldman initiated coverage on Glaukos with a new price target

    Goldman initiated coverage of Glaukos with a rating of Buy and set a new price target of $103.00

    10/1/25 8:52:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Advisory: Pre-Market Update + SEC Chairman Paul Atkins to Deliver Keynote on Capital Markets at NYSE

    NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on December 2nd Stocks opened Tuesday in positive territory after Monday's fractional losses, following their strongest holiday-shortened week since May.Risk-off sentiment persists amid a crypto slump, sticky inflation concerns, lofty valuations, and questions around AI-driven returns.SEC Chairman Paul Atkins will ring the Opening Bell and later deliver a keynote at the NYSE, addressing IPO

    12/2/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market Update + NYSE Texas Reaches Milestone 100 Dual Listings

    NEW YORK, Dec. 1, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on December 1st Stocks are little changed Monday morning as trading begins for December. The S&P 500 and Dow ended November nearly unchanged, with concerns over lofty AI valuations weighing on major indexes.December is historically strong for markets—S&P 500 averages gains of over 1%, ranking as the third-best month since 1950, per Stock Trader's Almanac.NYSE Texas reached 100 dual listin

    12/1/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Texas Reaches Milestone of 100 Dual Listings

    The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that NYSE Texas has reached the milestone of 100 dual listings. NYSE Texas launched in March 2025 as the first securities exchange to be incorporated in Texas. "Achieving this milestone on NYSE Texas reflects the demand for the NYSE's best-in-class offerings in the pro-business environment fostered by Governor Abbott in the Lone Star State," said Lynn Martin, President, NYSE Group. "We are proud to be the venue of choice for these issuers, and we look forward to continuing this momentum well into the new year." Key highlights since launch inclu

    12/1/25 8:00:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $GKOS
    $ICE
    $JBS
    Leadership Updates

    Live Leadership Updates

    View All

    Lord Hill of Oareford Elected to Board of Directors of Intercontinental Exchange

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that its Board of Directors has elected The Rt. Hon. the Lord Hill of Oareford CBE (Lord Hill) as a new director, effective September 18, 2025. Lord Hill, who currently serves on the Board of Directors of ICE Endex Markets, a subsidiary of ICE, is also expected to join the Board of Directors of ICE Futures Europe subject to regulatory approval. "On behalf of the Board, I am pleased to welcome our colleague, Lord Hill, to his expanded role at ICE," said Jeffrey C. Sprecher, Founder, Chair and CEO of Intercontinental Exchange. "Lord Hill brings tremendous depth and breadth of experi

    9/18/25 4:15:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 22nd Markets are closely watching the Fed's economic policy symposium in Jackson Hole, where Chair Jerome Powell will speak at 10 a.m. ET.Nearly 70% of traders expect a Fed rate cut in September amid dual concerns about inflation and employment highlighted in the Fed's July meeting minutes.The Fed's July meeting minutes emphasized policymakers' concerns about both inflation ris

    8/22/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Mizuho Americas Joins ICE Clear Credit as Clearing Member

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that Mizuho Americas through its security-based swap dealer Mizuho Capital Markets LLC, part of Mizuho Financial Group (NYSE:MFG), has become a clearing member at ICE Clear Credit, the leading global clearinghouse for credit default swaps. "Mizuho Americas is excited to join ICE Clear Credit to enhance our product offering and approach to capital and risk management delivering efficiencies across our CDS portfolios," said Natalya Rasmussen, Chief Operating Officer, Fixed Income Division, Mizuho Americas. "The opportunity to centrally clear products is an important step forward for

    8/6/25 9:00:00 AM ET
    $ICE
    $MFG
    Investment Bankers/Brokers/Service
    Finance
    Major Banks

    $GKOS
    $ICE
    $JBS
    Financials

    Live finance-specific insights

    View All

    Intercontinental Exchange Approves Fourth Quarter Dividend of $0.48 per Share

    Intercontinental Exchange (NYSE:ICE), a leading global provider of technology and data, announced today a $0.48 per share dividend for the fourth quarter of 2025, which is up 7% from the $0.45 per share dividend paid in the fourth quarter of 2024. The cash dividend is payable on December 31, 2025 to stockholders of record as of December 16, 2025. The ex-dividend date is December 16, 2025. About Intercontinental Exchange Intercontinental Exchange, Inc. (NYSE:ICE) is a Fortune 500 company that designs, builds, and operates digital networks that connect people to opportunity. We provide financial technology and data services across major asset classes helping our customers access mission-c

    10/30/25 7:35:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Intercontinental Exchange Reports Strong Third Quarter 2025

    Intercontinental Exchange (NYSE:ICE): 3Q25 net revenues of $2.4 billion, +3% y/y   3Q25 GAAP diluted earnings per share (EPS) of $1.42, +25% y/y   3Q25 adj. diluted EPS of $1.71, +10% y/y   3Q25 operating income of $1.2 billion, +6% y/y; adj. operating income of $1.4 billion, +3% y/y   3Q25 operating margin of 49%; adj. operating margin of 59%   Through September 30, 2025, returned over $1.7 billion to stockholders, including $894 million in share repurchases   Jeffrey C. Sprecher,ICE Chair & Chief Executive Officer, said,"We are pleased to report our third quarter results, which extend our track record of revenue and earnings per

    10/30/25 7:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Glaukos Announces Third Quarter 2025 Financial Results

    Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the third quarter ended September 30, 2025. Key highlights include: Record net sales of $133.5 million in Q3 2025 increased 38% year-over-year on a reported basis and 37% year-over-year on a constant currency basis. Glaucoma record net sales of $110.2 million in Q3 2025 increased 45% year-over-year. U.S. Glaucoma record net sales of $80.8 million in Q3 2025 increased 57% year-over-year. Gross margin of approximately 78% and non-GAAP gross margin of appr

    10/29/25 4:05:00 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $GKOS
    $ICE
    $JBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Glaukos Corporation

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    11/14/24 1:21:45 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Glaukos Corporation (Amendment)

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    2/14/24 3:55:55 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Glaukos Corporation (Amendment)

    SC 13G/A - GLAUKOS Corp (0001192448) (Subject)

    2/13/24 5:41:34 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care